Posted on August 19th, 2010 by Health News
A new study led by Yale University in the US found that an ancient four-herb Chinese herbal remedy first described 1,800 years ago reduced gastrointestinal toxicity and boosted the antitumor effect of the chemotherapy drug CPT-11 (irinotecan) in mice with colon cancer. A paper on the study was published in the journal Science Translational Medicine on 18 August…
Read more
Filed under: Pharmacy News
Tags: cancer, Drug, medicine, Pharmacy
Related posts
- Æterna Zentaris Zentaris requests EMA Scientific Advice for Phase 3 program with perifosine (0)
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has requested Scientific Advice from the European Medicines Agency (EMA) to assure the acceptability of the recently initiated Phase 3 programs for the development of its lead anticancer compound, perifosine, in its two lead indications, multiple myeloma [...]
- When To Administer Food And Drugs Together (0)
A regulatory bias against taking oral anti-cancer medications with food places many patients at increased risk for an overdose and forces them to "flush costly medicines down the toilet," argues Mark Ratain, MD, an authority on cancer-drug dosing. In a commentary published early online Sept. 19 in the Journal of Clinical Oncology, Ratain, the Leon [...]
- Supply of childhood leukemia drug nearly exhausted (0)
A medicine to treat children's leukemia is in such short supply that hospitals may run out within weeks; meanwhile, families of people with Alzheimer's disease are clamoring to use a skin-cancer drug after a promising study in mice.
Read more
[tags] Pharmacy News [/tags]
- Study: Costs get in way of cancer patients refilling their prescriptions (0)
About 10 percent of cancer patients aren't taking the oral medicines they need either because of the cost or they feel they are already taking too many other drugs, according to a study released by health-care consulting company Avalere Health late Wednesday.
Read more
[tags] Pharmacy News [/tags]
- Study suggests potential of ARC man-made compound in combination with Abbott’s ABT-737 for cancer (0)
Adding a second agent may make a new, experimental anti-cancer drug effective against a wide range of cancers, researchers at the University of Illinois at Chicago College of Medicine have found.
Read more
[tags] Pharmacy News [/tags]
Leave a Reply